The ambition for a one-and-done vision-saving AAV vector
Saved in:
Main Author: | Therese Cronin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050125000099 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AAV-based vectors for human diseases modeling in laboratory animals
by: Timur I. Aliev, et al.
Published: (2025-02-01) -
CRISPR screen reveals modifiers of rAAV production including known rAAV infection genes playing an unexpected role in vector production
by: Emily E. O’Driscoll, et al.
Published: (2025-03-01) -
Policy Advice between Ambition and Reality
by: Armin Steinbach
Published: (2022-07-01) -
Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primates
by: Mengping Liu, et al.
Published: (2025-03-01) -
Preclinical use of a clinically-relevant scAAV9/SUMF1 vector for the treatment of multiple sulfatase deficiency
by: Maximiliano Presa, et al.
Published: (2025-01-01)